Gainers
- Precision BioSciences (NASDAQ:DTIL) stock increased by 6.6% to $1.29 during Monday's after-market session. The company's market cap stands at $143.1 million.
- Benitec Biopharma (NASDAQ:BNTC) stock moved upwards by 4.65% to $0.27. The company's market cap stands at $7.5 million.
- Trevena (NASDAQ:TRVN) shares rose 4.63% to $1.58. The company's market cap stands at $12.1 million.
- Lixte Biotech Hldgs (NASDAQ:LIXT) stock moved upwards by 4.62% to $0.85. The company's market cap stands at $14.1 million.
- X4 Pharmaceuticals (NASDAQ:XFOR) shares rose 4.53% to $1.04. The company's market cap stands at $126.3 million.
- Adamis Pharmaceuticals (NASDAQ:ADMP) stock moved upwards by 4.18% to $0.23. The company's market cap stands at $34.3 million.
Losers
- Collegium Pharmaceutical (NASDAQ:COLL) stock fell 9.9% to $25.0 during Monday's after-market session. The company's market cap stands at $839.2 million.
- Rubius Therapeutics (NASDAQ:RUBY) shares declined by 8.07% to $0.31. The market value of their outstanding shares is at $28.0 million.
- Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock fell 8.03% to $1.72. This security traded at a volume of 107.4K shares come close, making up 72.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
- Quoin Pharmaceuticals (NASDAQ:QNRX) stock declined by 5.79% to $2.28. The market value of their outstanding shares is at $11.0 million.
- 9 Meters Biopharma (NASDAQ:NMTR) shares fell 4.99% to $2.48. The market value of their outstanding shares is at $32.1 million.
- Humanigen (NASDAQ:HGEN) stock declined by 4.94% to $0.21. Today's trading volume for this security ended up closing at 514.9K shares, which is 18.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $25.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.